-The Hindu Business Line The onus of granting approvals to Medicines marketed in the country is on the regulator Drug Controller General of India (DCGI), say drug companies, adding that they have adhered to the law of the land. The drug-makers were responding to a Parliamentary panel report on health that severely indicted the drug regulatory authority, besides alleging that “invisible hands” of drug-makers were involved in getting favourable reports on Medicines...

The debate about essential-Medicine pricing and access in India illustrates the difficulties inherent in establishing policies that serve conflicting public interests in achieving goals such as caring well and ensuring safety for all, while also pursuing financially-sustainable success in scientific innovation and trade. It highlights problems facing those interested in continuing drug and vaccines development and ensuring that, once marketed, such products contribute effectively to improving public health. Modern pharmaceuticals...

-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...

It has been a slow but steady move to make scholarship freely available Most of us spend a few hundred rupees a year on the magazines we buy for leisure reading or for keeping abreast of current affairs. But if you are a scientist, you may be shelling out a few thousand rupees for the journal your professional society publishes for its members. Of course, if you are a serious researcher,...

-The United Nations Some 15 million babies worldwide – more than one in ten births – are born too early, according to a new United Nations-backed report, released today, which calls for steps such as ensuring the requisite Medicines and equipment and training health staff to promote child survival. “All newborns are vulnerable, but preterm babies are acutely so,” says Secretary General Ban Ki-moon, who wrote the foreword to the report, entitled...